133 related articles for article (PubMed ID: 12541781)
1. [Role of epithelial cell proliferation and apoptosis in human middle ear cholesteatoma].
Zhu W; Huang D; Jing L; Zhang F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jul; 15(7):291-2, 295. PubMed ID: 12541781
[TBL] [Abstract][Full Text] [Related]
2. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
Yu Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
5. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
6. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
Olszewska E; Chodynicki S; Chyczewski L
Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
[TBL] [Abstract][Full Text] [Related]
8. [Markers of epidermal proliferation in middle ear cholesteatoma].
Hassmann-Poznańska E; Skotnicka B; Dziecioł J
Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
[TBL] [Abstract][Full Text] [Related]
9. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
Durko M; Kaczmarczyk D
Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
11. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
[TBL] [Abstract][Full Text] [Related]
12. Some markers of proliferative activity in cholesteatoma epithelium in adults.
Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation and apoptosis in human middle ear cholesteatoma.
Kojima H; Tanaka Y; Tanaka T; Miyazaki H; Shiwa M; Kamide Y; Moriyama H
Arch Otolaryngol Head Neck Surg; 1998 Mar; 124(3):261-4. PubMed ID: 9525508
[TBL] [Abstract][Full Text] [Related]
14. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
15. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
[TBL] [Abstract][Full Text] [Related]
16. [DNA character of the cholesteatoma].
Cui Y; Pan H; Gao Q
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
18. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
19. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]